Ankylosing spondylitis (AS) is the most frequent and most severe subtype of
spondyloarthritis and can be an outcome of any of the other spondyloarthritis subtypes. It …

Acute anterior uveitis is the most common form of uveitis. HLA-B27-associated acute anterior
uveitis is a distinct clinical entity that has wide-ranging medical significance due to its ocular …

Objective: To develop evidence based recommendations for the management of ankylosing
spondylitis (AS) as a combined effort of the 'ASsessment in AS'international working group …

Objective To estimate the incidence of anterior uveitis in patients with ankylosing spondylitis
(AS) who underwent anti–tumor necrosis factor (anti‐TNF) therapy, using data from recently …

Background Ankylosing spondylitis (AS) is a chronic inflammatory disease of unknown
cause and affects mainly the spine, but can also affect other joints. Disease progression may …

Objective: To evaluate the effect of adalimumab on the frequency of anterior uveitis (AU)
flares in patients with active ankylosing spondylitis (AS). Methods: We determined the history …

Uveitis is the most frequent extra-articular manifestation of axial spondyloarthritis (SpA),
occurring in up to one-third of the patients. In the majority of patients, uveitis is acute, anterior …

Objective Etanercept, a fully human tumor necrosis factor (TNF) receptor, is an effective
treatment in patients with ankylosing spondylitis (AS). Sulfasalazine is frequently used for …

Uveitis is a frequently occurring extra-articular manifestation of spondyloarthropathies
(SpAs), ankylosing spondylitis (AS), reactive arthritis (ReA), psoriatic arthritis (PsA) and …

Objectives Tumour necrosis factor-α inhibitor (TNFi) treatment has been shown to reduce the
rates of anterior uveitis (AU) in patients with ankylosing spondylitis (AS). Our objective was …